Difficulty: Medium
Average Score: 90%
Practice
Caution should be taken regarding clients who have been prescribed guaifenesin in the presence of asthma diagnosis because
Correct answer
A
Rationale
In this scenario, the correct answer is A) guaifenesin can cause bronchospasm. When dealing with clients who have asthma, it is crucial to be cautious with medications that can potentially trigger or exacerbate bronchospasm, as this can lead to severe respiratory distress. Guaifenesin is known to have the potential to induce bronchospasm in some individuals, particularly those with underlying respiratory conditions like asthma.
Option B) guaifenesin can cause bronchoconstriction, while similar to bronchospasm, is not the primary concern in asthma management. Bronchoconstriction refers to the narrowing of the airways due to smooth muscle contraction, which can contribute to breathing difficulties, but it is not as directly related to asthma exacerbations as bronchospasm.
Option C) guaifenesin can cause decreased diameter of bronchial lumina is a distractor that is not physiologically accurate. Guaifenesin is not typically associated with directly decreasing the diameter of the bronchial lumina, which is why this option is incorrect.
Educationally, understanding the potential effects of medications on specific patient populations, such as those with asthma, is crucial for healthcare providers to ensure safe and effective care. By being aware of the risks associated with certain medications like guaifenesin in asthma patients, healthcare professionals can make informed decisions to prevent adverse outcomes and provide optimal patient care.
Option B) guaifenesin can cause bronchoconstriction, while similar to bronchospasm, is not the primary concern in asthma management. Bronchoconstriction refers to the narrowing of the airways due to smooth muscle contraction, which can contribute to breathing difficulties, but it is not as directly related to asthma exacerbations as bronchospasm.
Option C) guaifenesin can cause decreased diameter of bronchial lumina is a distractor that is not physiologically accurate. Guaifenesin is not typically associated with directly decreasing the diameter of the bronchial lumina, which is why this option is incorrect.
Educationally, understanding the potential effects of medications on specific patient populations, such as those with asthma, is crucial for healthcare providers to ensure safe and effective care. By being aware of the risks associated with certain medications like guaifenesin in asthma patients, healthcare professionals can make informed decisions to prevent adverse outcomes and provide optimal patient care.